Latham Steers Pharma Co. In $100M Follow-On Offering
Clinical-stage pharmaceutical company Crinetics Pharmaceuticals Inc. on Wednesday priced a $100.1 million follow-on public offering steered by Latham & Watkins LLP that Crinetics said would help fund further drug development....To view the full article, register now.
Already a subscriber? Click here to view full article